Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain setJoanna Tieu, Catherine Hill, Nilasha Ghosh et al.|Seminars in Arthritis and Rheumatism|2021Cited by 12
Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working GroupJonathan T. L. Cheah, Catherine Hill, Rachel Black et al.|The Journal of Rheumatology|2019Cited by 10